AAPS Gateway 2012: Shimadzu Scientific Instruments - Pharmaceutical Technology

Latest Issue
PharmTech

Latest Issue
PharmTech Europe

AAPS Gateway 2012: Shimadzu Scientific Instruments


Shimadzu Scientific Instruments
7102 Riverwood Drive
Columbia, MD 21046
Phone: 800-477-1227
Fax: 410-381-1222
Email: webmaster@shimadzu.com
Website: www.ssi.shimadzu.com
AAPS 2012 Booth #: 4304

Company Description
Headquartered in Columbia, Maryland, Shimadzu Scientific Instruments offers a full line of analytical measurement and testing instrumentation for a broad range of applications in science and industry. Products include chromatographs (HPLC/UFLC/UHPLC, GC); mass spectrometers (GC/MS/MS, LC/MS/MS, MALDI); spectrophotometers (FT-IR, Fluorescence, UV-VIS-NIR); atomic (AA, ICP) and X-ray (EDX, XRD, XRF) spectrometers; thermal analyzers; Total Organic Carbon (TOC) analyzers; particle size analyzers; balances; and materials testers.

With a vast installed base and preferred vendor status at many institutions, our instruments are used by top researchers across the globe; customers who can count on the stability, experience, and support only Shimadzu offers.

Booth Invitation
Shimadzu invites you to visit us at AAPS 2012 where we’ll be showcasing a wide range of solutions for the pharmaceutical industry. Our instruments are used throughout the pharmaceutical pipeline, from proteomics research and drug discovery/development to QA/QC and manufacturing, providing a total solution to researchers working within pharmaceutical industries.

On display will be a suite of HPLC/UHPLC systems, triple quad LC/MS/MS, TOC analyzers, GC/GCMS, UV-Vis and FTIR spectrophotometers, an automated mass spec sample prep system, and balances. The new triple quad LCMS-8040 offers an unmatched fusion of speed and sensitivity, ensuring high-throughput analysis at lower levels of detection.

Shimadzu’s LCMS-8040 Triple Quad LC/MS/MS


PDF/Online Documents

  1. Shimadzu’s New Triple Quadrupole LCMS-8040 Combines Ultra High Speed with Enhanced Sensitivity for an Expanded Range of Applications

  2. Cleaning Validation: Which TOC Technique is Best?

  3. UV-Vis Performance Validation Software for Improved GLP/GMP Support

  4. Fast LC-MS/MS Screening Method for Antipsychotics

  5. Analysis of Dimethicone Based on USP-Specified Method

  6. Analysis of Hemoglobin Variants using an Automated Sample Preparation Workstation Coupled to LC-MS

  7. Study of an Efficient Method Development and Analysis Preparation Process using UHPLC

  8. New SALD-2300 Achieves Quick, High-Resolution Particle Size Distribution Analysis

ADVERTISEMENT

blog comments powered by Disqus
LCGC E-mail Newsletters

Subscribe: Click to learn more about the newsletter
| Weekly
| Monthly
|Monthly
| Weekly

Survey
How does your company apply quality-by-design (QbD) principles to manufacturing processes?
To all processes for both new and legacy products
To all process for new products only
To select process for new products only
To select processes for both new and legacy products
Do not use QbD
To all processes for both new and legacy products
18%
To all process for new products only
14%
To select process for new products only
23%
To select processes for both new and legacy products
20%
Do not use QbD
25%
View Results
UPCOMING CONFERENCES

Programs for Investigational and Pre-Launch Drugs
Philadelphia, PA
July 17-18, 2013
Request Brochure

Strategic Pipeline Planning & Portfolio Valuation
Philadelphia, PA
August 13-14, 2013
Request Brochure

MES 2013 - Forum on Manufacturing Execution Systems
Philadelphia, PA
August 14-15, 2013
Request Brochure

Mobile Innovation for the Life Sciences Industry
Philadelphia, PA
August 20-21, 2013
Request Brochure

See All Conferences >>

Eric Langer Outsourcing Outlook Eric LangerOutsourcing's Modest Role as a Cost-Containment Strategy
Patricia Van Arnum Ingredients Insider Patricia Van ArnumIntellectual Property Battles in Solid-State Chemistry
Nathan Jessop Industry Insider Nathan Jessop Campaign Against Counterfeit Drugs Continues
Lynn Torbeck Statistical Solutions Lynn D. TorbeckCompositing Samples and the Risk to Product Quality
 More
FDA Offers Insight on QbD for Modified-Release Products
Global Biosimilars Market to Reach $2.445 Billion in 2013
Adapting to Change
AstraZeneca and Exco InTouch Collaborate to Augment Current COPD Pathways
Overcoming the Challenges in Biopharmaceutical Stability Testing
FindPharma Custom Search

Click here